Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: Implication for neonatal screening of congenital adrenal hyperplasia

Pediatric Research

Volumn 56, Issue 5, 2004, Pages 701-705

  Gatelais, Frédérique ^a   Berthelot, Jacques ^a   Beringue, Frédérique ^a   Descamps, Philippe ^a   Bonneau, Dominique ^a   Limal, Jean Marie ^a   Coutant, Régis ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; HYDROXYPROGESTERONE;

ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIAGNOSTIC ACCURACY; DRUG EFFECT; FEMALE; FETUS LUNG MATURATION; HUMAN; INTRAUTERINE GROWTH RETARDATION; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; MULTIPLE DRUG DOSE; MULTIPLE REGRESSION; NEWBORN; NEWBORN SCREENING; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RANK SUM TEST; RESPIRATORY DISTRESS SYNDROME; SINGLE DRUG DOSE;

17-ALPHA-HYDROXYPROGESTERONE; ADRENAL CORTEX HORMONES; ADRENAL HYPERPLASIA, CONGENITAL; APGAR SCORE; BETAMETHASONE; BIRTH WEIGHT; DELIVERY, OBSTETRIC; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; NEONATAL SCREENING; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; REGRESSION ANALYSIS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SEPSIS;

EID: 6344256661     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000142733.50918.6E     Document Type: Article

References (37)

1. Speiser PW, White PC 2003 Congenital adrenal hyperplasia. N Engl J Med 349:776-788
2. Pang S, Hotchkiss J, Drash AL, Levine LS, New MI 1977 Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for the rapid screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 45:1003-1008
3. Pang SY, Wallace MA Hofman L, Thuline HC, Dorche C, Lyon IC, Dobbins RH, Kling S, Fujieda K, Suwa S 1988 Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 81:866-874
4. Pang S, Shook MK 1997 Current status of neonatal screening for congenital adrenal hyperplasia. Curr Opin Pediatr 9:419-423
5. Cartigny-Maciejewski M, Guilley N, Vanderbecken S, Gonde S, Stuckens C, Ponte C, Weill J, Farriaux JP, Paux E 1999 [Neonatal screening of congenital adrenal hyperplasia due to 21- hydroxylase deficiency: Lille experience 1980-1996]. Arch Pediatr 6:151-158
6. Döerr HG, Sippell WG, Versmold HT, Bidlingmaier F, Knorr D 1988 Plasma mineralocorticoids, glucocorticoids, and progestins in premature infants: longitudinal study during the first week of life. Pediatr Res 23:525-529
7. Allen DB, Farrell PM 1996 Newborn screening: principles and practice. Adv Pediatr 43:231-270
8. al Saedi S, Dean H, Dent W, Stockl E, Cronin C 1996 Screening for congenital adrenal hyperplasia: the Delfia Screening Test overestimates serum 17-hydroxyprogesterone in preterm infants. Pediatrics 97:100-102
9. Lee MM, Rajagopalan L, Berg GJ, Moshang T Jr 1989 Serum adrenal steroid concentrations in premature infants. J Clin Endocrinol Metab 69:1133-1136
10. Nordenstrom A, Wedell A, Hagenfeldt L, Marcus C, Larsson A 2001 Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants. Pediatrics 108:E68
11. Linder N, Davidovitch N, Kogan A, Barzilai A, Kuint J, Mazkeret R, Sack J 1999 Longitudinal measurements of 17alpha-hydroxyprogesterone in premature infants during the first three months of life. Arch Dis Child Fetal Neonatal Ed 81:F175-F178
12. Pass KA, Lane PA, Fernhof PM, Hinton CF, Panny SR, Park JS, Pelias MZ, Rhead WJ, Ross SI, Wethers DL, Elsas LJ 2nd, for CORN 2000 US Newborn Screening System Guidelines II: follow-up of children, diagnosis, management, and evaluation statement of the Council of Regional Networks for Genetic Services (CORN). J Pediatr 137:S1-S46
13. Liggins GC, Howie RN 1972 A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 50:515-525
14. 1994 Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consens Statement 12:1-24
15. 2001 Antenatal corticosteroids revisited: repeat courses-National Institutes of Health Consensus Development Conference Statement, August 17-18, 2000. Obstet Gynecol 98:144-150
16. Walfisch A, Hallak M, Mazor M 2001 Multiple courses of antenatal steroids: risks and benefits. Obstet Gynecol 98:491-497
17. Wijnberger LD, Mosten JM, van Dam KI, Mol BW, Brouwers H, Visser GH 2002 Comparison of single and repeated antenatal corticosteroid therapy to prevent neonatal death and morbidity in the preterm infant. Early Hum Dev 67:29-36
18. David M, Forest MG 1984 Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. J Pediatr 105:799-803
19. Pang SY, Pollack MS, Marshall RN, Immken L 1990 Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 322:111-115
20. Forest MG, Morel Y, David M 1998 Prenatal treatment of congenital adrenal hyperplasia. Trends Endocrinol Metab 9:284-289
21. New MI, Carlson A, Obeid J, Marshall I, Cabrera MS, Goseco A, Lin-Su K, Putnam AS, Wei JQ, Wilson RC 2001 Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab 86:5651-5657
22. Joint LWPES/ESPE CAH Working Group 2002 Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. J Clin Endocrinol Metab 87:4048-4053
23. Leroy B, Lefort F 1971 [The weight and size of newborn infants at birth]. Rev Fr Gynecol Obstet 66:391-396
24. King JL, Naber JM, Hopkin RJ, Repaske DR, Bailey L, Leslie ND 2001 Antenatal corticosteroids and newborn screening for congenital adrenal hyperplasia. Arch Pediatr Adolesc Med 155:1038-1042
25. Ballard PL, Gluckman PD, Liggins GC, Kaplan SL, Grumbach MM 1980 Steroid and growth hormone levels in premature infants after prenatal betamethasone therapy to prevent respiratory distress syndrome. Pediatr Res 14:122-127
26. Kari MA, Raivio KO, Stenman UH, Voutilainen R 1996 Serum cortisol, dehydroepiandrosterone sulfate, and steroid-binding globulins in preterm neonates: effect of gestational age and dexamethasone therapy. Pediatr Res 40:319-324
27. Nomura S 1997 Immature adrenal steroidogenesis in preterm infants. Early Hum Dev 49:225-233
28. Murphy JF, Joyce BG, Dyas J, Hughes IA 1983 Plasma 17-hydroxyprogesterone concentrations in ill newborn infants. Arch Dis Child 58:532-534
29. Larsson A, Hagenfeldt L, von Dobeln U, Curstedt T, Gustafsson J, Svensson E 1988 Neonatal screening for congenital adrenal hyperplasia using 17-hydroxyprogesterone assay in filter paper blood spots. Horm Res 30:235-240
30. Shimozawa K, Matsumoto M, Okada K, Murata M, Tsuchiya Y, Kitagawa T 1988 Analysis of blood spot 17 alpha-hydroxyprogesterone concentration in neonates. Horm Res 30:246-251
31. Knudtzon J, Markestad T, Aakvaag A, Bergsjo P 1991 Elevated 17-hydroxyprogesterone levels in premature infants. Acta Paediatr Scand 80:96-97
32. Lange-Kubini K, Zachmann M, Kempken B, Torresant T 1996 15 beta-hydroxylated steroids may be diagnostically misleading in confirming congenital adrenal hyperplasia suspected by a newborn screening programme. Eur J Pediatr 155:928-931
33. Bolt RJ, van Weissenbruch MM, Popp-Snijders C, Sweep CG, Lafeber HN, Delemarre-van de Waal HA 2002 Fetal growth and the function of the adrenal cortex in preterm infants. J Clin Endocrinol Metab 87:1194-1199
34. Allen DB, Hoffman GL, Fitzpatrick P, Laessig R, Maby S, Slyper A 1997 Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels. J Pediatr 130:128-133
35. Therrell BL Jr, Berenbaum SA, Manier-Kapanke V, Simmank J, Korman K, Prentice L, Gonzales J, Gunn S 1998 Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 101:583-590
36. Ohkubo S, Shimozawa K, Matsumoto M, Kitagawa T 1992 Analysis of blood spot 17 alpha-hydroxyprogesterone concentration in premature infants-proposal for cut-off limits in screening for congenital adrenal hyperplasia. Acta Paediatr Jpn 34:126-133
37. Gudmundsson K, Majzoub JA, Bradwin G, Mandel S, Rifai N 1999 Virilising 21-hydroxylase deficiency: timing of newborn screening and confirmatory tests can be crucial. J Pediatr Endocrinol Metab 12:895-901